Noopur Raje
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments 365
- Oncology top 0.05%
- Peptidase Inhibition and Analysis 81
- Bone health and treatments 68
- CAR-T cell therapy research 68
- Cancer Treatment and Pharmacology 40
- Molecular Biology top 0.2%
- Protein Degradation and Inhibitors 114
- Histone Deacetylase Inhibitors Research 34
- Genetics top 0.5%
- Immunology top 0.5%
-
- Monoclonal and Polyclonal Antibodies Research 32
- Co-authors
- Kenneth C. AndersonTeru HideshimaPaul G. RichardsonDharminder ChauhanNikhil C. MunshiKlaus PodarYu‐Tzu TaiSonia Vallet
- Cited by
- HematologyOncologyMolecular Biology
- Journals
- New England Journal of Medicine (4 papers)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- United StatesFranceSpain
In The Last Decade
Noopur Raje
480 papers receiving 19.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Hematology 11.2k
- Oncology 10.1k
- Molecular Biology 12.0k
- Genetics 1.7k
- Immunology 2.8k
Countries citing papers authored by Noopur Raje
This map shows the geographic impact of Noopur Raje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noopur Raje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noopur Raje more than expected).
Fields of papers citing papers by Noopur Raje
This network shows the impact of papers produced by Noopur Raje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noopur Raje. The network helps show where Noopur Raje may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Noopur Raje, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 2 | |
| 9 | Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panelbreakdown → | 2023 | 77 |
| 10 | 2023 | 76 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 2 | |
| 13 | 2019 | 39 | |
| 14 | 2019 | 82 | |
| 15 | 2016 | 22 | |
| 16 | 2014 | 123 | |
| 17 | 2014 | 24 | |
| 18 | 2010 | 136 | |
| 19 | 2009 | 53 | |
| 20 | 2007 | 55 |
About Noopur Raje
Noopur Raje is a scholar working on Hematology, Oncology and Genetics, having authored 497 papers that have together received 20.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (365 papers), Protein Degradation and Inhibitors (114 papers), Peptidase Inhibition and Analysis (81 papers), Bone health and treatments (68 papers), CAR-T cell therapy research (68 papers), Cancer Treatment and Pharmacology (40 papers), Histone Deacetylase Inhibitors Research (34 papers) and Monoclonal and Polyclonal Antibodies Research (32 papers). The work is most often cited by research in Hematology (11.2k citations), Oncology (10.1k citations) and Molecular Biology (12.0k citations). Noopur Raje has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Kenneth C. Anderson, Teru Hideshima, Paul G. Richardson, Dharminder Chauhan, Nikhil C. Munshi, Klaus Podar, Yu‐Tzu Tai, Sonia Vallet, Steven P. Treon and Constantine S. Mitsiades. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.